Literature DB >> 19427231

China's growing biomedical industry.

Pei Han1.   

Abstract

The biomedical industry in China is developing rapidly, and new biological drugs are increasing their share of the pharmaceutical market based on people's needs. China is the largest producer and user of vaccines in the world, but the existing production of vaccines is far from enough to meet the needs of the market. The entire market of biological drugs in China is still smaller than that for traditional medicines and chemicals. Therefore, the biopharmaceutical industry has the potential to be the rising star in the pharmaceutical market in the future.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427231     DOI: 10.1016/j.biologicals.2009.02.010

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  3 in total

1.  Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).

Authors:  Hao Hu; Chao-Chen Chung
Journal:  Int J Health Policy Manag       Date:  2015-09-03

2.  The Emerging Neurobioeconomy: Implications for National Security.

Authors:  Joseph DeFranco; Maureen Rhemann; James Giordano
Journal:  Health Secur       Date:  2020 Jul/Aug

3.  Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.

Authors:  Wen Chen; Shenglan Tang; Jing Sun; Dennis Ross-Degnan; Anita K Wagner
Journal:  BMC Health Serv Res       Date:  2010-07-17       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.